(Q33181384)

23 July 2017

1 reference

title

Recombinant antibodies: a novel approach to cancer diagnosis and therapy (English)

1 reference

23 July 2017

1 reference

1 reference

Hudson PJ

1

1 reference

PubMed ID

11060739

23 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Expert Opinion on Investigational Drugs

23 July 2017

1 reference

23 July 2017

9

1 reference

23 July 2017

1231-1242

1 reference

23 July 2017

6

1 reference

Clinical applications of anti-CD20 antibodies.

23 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Display technologies expand their horizons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Beyond binding: using phage display to select for structure, folding and enzymatic activity in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Signaling antibodies in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

High avidity scFv multimers; diabodies and triabodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Generating improved single-chain Fv molecules for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Bispecific antibodies in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Phage library-derived human anti-TETA and anti-DOTA ScFv for pretargeting RIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Strategies to adapt adenoviral vectors for targeted delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Immunotoxins in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Multiple event activation of a generic prodrug trigger by antibody catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Cellular delivery of hammerhead ribozymes conjugated to a transferrin receptor antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Targeted gene delivery to mammalian cells by filamentous bacteriophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Construction, expression, and characterization of anticarcinoma sFv fused to IL-2 or GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Dendritic cell vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Selection for improved protein stability by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Generation of a large complex antibody library from multiple donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Exploiting recombination in single bacteria to make large phage antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Ribosome display: an in vitro method for selection and evolution of antibodies from libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Selection of a human anti-progesterone antibody fragment from a transgenic mouse library by ARM ribosome display

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Selectively infective phage (SIP) technology: scope and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Fine affinity discrimination by yeast surface display and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen 1 1Edited by P. E. Wright

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.6.1231

10.1517/13543784.9.6.1231

21 January 2018

Identifiers

DOI

1 reference

23 July 2017

1 reference

PubMed ID

11060739